Biogen’s Spinraza has competition in Argentina. The local drugmaker Gador has launched a generic of the spinal muscular atrophy drug under the brand name Ligonux. Launched at an event attended by pediatric neurologists at the Centro Audiovisual Inmersivo de Buenos Aires today, it’s the only generic Spinraza outside of Russia.

The launch event was led by company director Alfredo Weber, while speakers included Soledad Monges, head of neurology at Hospital Garrahan, Mariela Lucero, head of pediatric neurology at Sor María Ludovica de La Plata Children’s Hospital and Natalia Messina, the former director of special and high-cost medicines at Argentina’s Ministry of Health. The latter official played a key role in shaping the shared risk model for high-cost treatments. See article in Spanish.

Read more >>